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Clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR-
associated (Cas) system has recently been discovered as a prokaryotic adaptive 
immune mechanism against invading viruses and plasmids. Among various types of 
the CRISPR/Cas systems, type-II consists of Cas9 endonuclease and two guide 
RNAs (gRNA), CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA), 
whose ribonucleoprotein complex recognizes and cleaves target DNA. Although 
extensive structural studies of Cas9-gRNA complex has been carried out since the 
CRISPR/Cas9 system was successfully employed to genome editing, the detailed 
mechanism and dynamics of gRNAs in the structural activation of the Cas9 
endonuclease are still elusive.   
ii 
Herein, we review our studies on the structural roles of the two guide RNAs 
in the activation of Cas9 endonuclease using pseudo-ensemble and single-molecule 
fluorescence spectroscopic assays, thereby providing mechanistic details which are 
not available from other static and/or ensemble-averaged measurements. Firstly, 
tracrRNA was found to be critical in the formation of functional Cas9-gRNA 
complex (Cas9:gRNA). In the absence of tracrRNA, the Cas9 protein became 
inactivated so that it failed to form Cas9:gRNA, whereas tracrRNA-Cas9 interaction 
prevented the inactivation pathway by leading Cas9 toward a complexation pathway 
for Cas9:gRNA. Secondly, crRNA was found to regulate the nuclease activation of 
Cas9 after Cas9:gRNA bound to the target DNA with forming Cas9-gRNA-DNA 
ternary complex (Cas9:gRNA:DNA). R-loop structure between crRNA and the 
target DNA in Cas9:gRNA:DNA exhibited intrinsically repetitive transitions 
between two distinct sub-conformations termed ‘open’ and ‘zipped’ conformations. 
This crRNA-related conformational dynamics was proved to be a crucial factor for 
the nuclease activation by the observation that the bound DNA was cleaved only 
when the zipped conformation formed. Overall, these results show mechanistic 
insights into the gRNA-associated structural activation of the Cas9 endonuclease. 
 
Keywords: Single-molecule spectroscopy, Total internal reflection 
fluorescence microscopy, Fluorescence resonance energy transfer, 
CRISPR/Cas9, Structural dynamics, Enzymatic mechanism 
 
Student Number: 2015-20386 
iii 
Table of Contents 
Abstract ..................................................................................................................... i 
Table of Contents .................................................................................................. iii 
1.  Introduction .................................................................................................... １ 
2.  Basic Principles ............................................................................................... ５ 
2.1.  Single-molecule Fluorescence Spectroscopy .............................................６ 
2.1.1.  Introduction: advantages of single-molecule spectroscopy .................６ 
2.1.2.  Fluorescence resonance energy transfer (FRET) ................................６ 
2.1.3.  Total internal reflection fluorescence (TIRF) microscopy .............. １３ 
2.1.4.  Enhancement of single-fluorophore photo-stability ........................ １８ 
2.2.  CRISPR/Cas9 System ............................................................................ ２０ 
2.2.1.  Structural rearrangement of Cas9 induced by guide RNA .............. ２１ 
2.2.2.  Mechanism of gRNA-DNA heteroduplexation in Cas9:gRNA:DNA 
complexation ................................................................................................ ２２ 
2.2.3.  Nuclease activity of Cas9 related to PAM-distal complementarity 
between crRNA and DNA............................................................................ ２３ 
3.  Inhibitory Effect of tracrRNA on Conformational Inactivation of Cas9 
 ............................................................................................................................ ２５ 
3.1.  Introduction ............................................................................................ ２６ 
3.2.  Materials and Methods ........................................................................... ２６ 
3.3.  Results and Discussion ........................................................................... ３０ 
3.3.1.  Visualization of Cas9 nuclease activity at single-molecule level.... ３０ 
3.3.2.  Identification of inactivated apo-Cas9 in the absence of tracrRNA 
 ...................................................................................................................... ３３ 
3.3.3.  tracrRNA-involved recovery to functionally active Cas9:gRNA ... ３８ 
3.4.  Conclusion .............................................................................................. ４１ 
 
iv 
4.  Regulatory Effect of Sub-conformational Transition of crRNA on 
Nuclease Activation of Cas9 Complex .............................................................. ４２ 
4.1.  Introduction ............................................................................................ ４３ 
4.2.  Materials and Methods ........................................................................... ４３ 
4.3.  Results and Discussion ........................................................................... ４６ 
4.3.1.  Real-time observation of Cas9:gRNA binding to DNA at single-
molecule level .............................................................................................. ４６ 
4.3.2.  Conformational heterogeneity in crRNA-DNA heteroduplex ........ ４８ 
4.3.3.  crRNA-controlled conformational distribution in R-loop structure in 
Cas9:gRNA:DNA......................................................................................... ５１ 
4.3.4.  Nuclease activity of Cas9 regulated by the conformational transition
 ...................................................................................................................... ５３ 
4.4.  Conclusion .............................................................................................. ５７ 
5.  Conclusion .................................................................................................... ５９ 
References ........................................................................................................... ６２ 
Appendix ............................................................................................................. ６５ 











Recently, prokaryotes (most archaea and nearly 40% of bacteria) are found to have 
an adaptive immune system, termed clustered regularly interspaced short 
palindromic repeats (CRISPR) / CRISPR-associated (Cas) system, which defends 
themselves against foreign nucleic acids (DNA or RNA) from invasive 
bacteriophages and plasmids1–3. The brief mechanism of action of CRISPR/Cas 
system is as follows: 1) CRISPR RNA (crRNA), which contains individual short 
sequences (“spacer”) obtained from the foreign nucleic acid fragments 
(“protospacer”), is transcribed from the CRISPR locus of the genome4, 2) the crRNA, 
in the form of crRNA-Cas protein effector complex, recognizes the target nucleic 
acid sequences via Watson-Crick base-pairing with Cas proteins inducing targeted 
double-strand breaks to destroy the invading nucleic acids5. 
      Among the three major types of CRISPR/Cas systems, the type-II 
CRSPR/Cas system has been exclusively employed to in vitro and in vivo genome 
editing due to its simple handling as well as high specificity6. In the type-II system, 
only one protein, Cas9, with two guide RNAs (gRNAs), crRNA and trans-activating 
crRNA (tracrRNA), is required to form a functional RNA-guided endonuclease 
complex7. The Cas9-gRNA complex (Cas9:gRNA) recognizes and cleaves the target 
DNA sequences which contain protospacer and protospacer-adjacent motif (PAM) 
right next to the protospacer sequence8–10. 
Since Cas9 from Streptococcus pyogenes was first applied to genome editing 
successfully in human cells11–14, extensive structural studies for the Cas9 system have 
been reported. The Cas9-gRNA interaction leads Cas9 to Cas9:gRNA, in which Cas9 
is structurally distinct from apo-Cas9, followed by further transitioning into the 
３ 
structure of the Cas9-gRNA-DNA ternary complex (Cas9:gRNA:DNA) upon 
binding to the target DNA, revealed by biochemical assays15, X-ray 
crystallography16–20, and single-particle cryo-electron microscopy19,20. These 
previous reports show that gRNAs are not only involved in R-loop expansion 
between the target DNA and crRNA but also critical for the protein domain 
rearrangement of Cas9 for the target DNA recognition and cleavage. However, the 
details, especially in the aspect of structural dynamics, of the two gRNAs in 
structural activation of the Cas9 nuclease remain to be elucidated. Therefore, we set 
out to explore the structural roles of gRNAs in the functional activation of Cas9 at 
single-molecule level. 
This thesis summarizes our single-molecule and single-molecule-based 
pseudo-ensemble investigations into the molecular mechanism of the two gRNAs on 
Cas9:gRNA complexation and the conformational changes related to the nuclease 
activity. In Chapter 2, we discuss the basic principles and major characteristics of the 
single-molecule fluorescence method and the CRISPR/Cas system, employed in 
these studies. The main results follow in Chapter 3 and 4; each chapter illustrates the 
newly unraveled structural roles of tracrRNA and crRNA, respectively. Using the 
pseudo-ensemble fluorescence spectroscopy, we discovered an inactivated apo-Cas9 
state, transition toward which was repressed by tracrRNA-Cas9 interaction (Chapter 
3). Moreover, real-time observation of Cas9:gRNA:DNA using the single-molecule 
fluorescence spectroscopy revealed sub-conformational heterogeneity and flexibility 
in the R-loop structure between crRNA and the target DNA, distribution of which 
regulated the nuclease activity of the Cas9 nuclease (Chapter 4). 
４ 
The employment of the single-molecule spectroscopic technique in 
monitoring Cas9:gRNA functioning results in that tracrRNA plays an initiative role 
in the formation pathway of functional Cas9:gRNA, whereas crRNA plays a 
regulatory role in the nuclease activation of Cas9:gRNA:DNA. By providing the 
mechanistic details on the gRNA-induced structural activation of the Cas9 nuclease, 
these studies contribute to the thorough understanding of the mechanism of action of 
the CRISPR/Cas9 system, thereby enabling more efficient genome editing. 
５ 







2.1. Single-molecule Fluorescence Spectroscopy 
2.1.1. Introduction: advantages of single-molecule spectroscopy 
Due to stochastic property of the nature, all chemical and thus biological processes 
occur stochastically, leading to heterogeneities for the chemical or biological 
complex systems. Most experimental techniques, however, measure ensemble-
averaged signals from a large number of molecules at heterogeneous states on the 
way of the processes, which lacks information on the identification, distribution, and 
dynamics of the sub-populations. Single-molecule technique overcomes this 
limitation completely. By detecting molecules one by one, the sub-populations can 
be readily identified and their distribution also be calculated directly. Furthermore, 
real-time single-molecule observation enables monitoring the dynamics of 
transitions between the sub-populations. Owing to these exclusive advantages, the 
single-molecule spectroscopy has been actively applied to study microscopic 
characteristics of numerous complex processes, especially in biological systems. 
2.1.2. Fluorescence resonance energy transfer (FRET) 
Fluorescence (Förster) resonance energy transfer (FRET) is a physically well-
established energy transfer process between two objects (FRET pair: donor and 
acceptor), in which energy from the excited donor directly transfer to the acceptor 
when the energy levels of the donor and acceptor are resonant. For a pair of 
fluorophores satisfying the resonance condition, the occurrence of FRET could be 
readily detected by the acceptor fluorescence with donor excitation. Since FRET 
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efficiency depends sharply on the inter-fluorophore distance in the range of 2-8 nm, 
which is consistent with the size of bio-macromolecules, it becomes one of the most 
powerful fluorescence spectroscopic technique to monitor biological processes 
involving binding or conformational rearrangement of bio-macromolecules (i.e. 
proteins and nucleic acids) at the molecular level. Further, combined with single-
molecule techniques, single-molecule FRET (smFRET) technique enables detection 
of transient intermediates, structural heterogeneity and dynamics during the reaction 
pathways of biological processes. 
      The FRET phenomenon naturally emerges from the quantum mechanical 
description of (induced) dipole-dipole interaction between the FRET pair. In the 
presence of the dipole interaction, the rate of the transition from a collective state of 
the donor excited and acceptor at the ground toward that of the donor at the ground 
and acceptor excited, which refers to the rate of FRET, can be expressed in terms of 
the transition matrix element between the excited state of donor and acceptor 





where 𝐷  and 𝐴  represent the ground states with 𝐷∗  and 𝐴∗  representing the 
excited states of the donor and acceptor, respectively, and 𝐻′̂  is the interaction 
Hamiltonian for the dipole-dipole interaction potential. The interaction 
Hamiltonian, 𝐻′̂, can be expressed as: 
𝐻′̂ =
𝜇𝐷⃗⃗ ⃗⃗  ∙ 𝜇𝐴⃗⃗ ⃗⃗ 
𝑅3
−
3(𝜇𝐷⃗⃗ ⃗⃗  ∙ ?⃗? )(𝜇𝐴⃗⃗ ⃗⃗ ∙ ?⃗? )
𝑅5
 
where 𝜇𝐷⃗⃗ ⃗⃗   and 𝜇𝐴⃗⃗ ⃗⃗  are dipole moments of the donor and acceptor, respectively, and 
８ 
?⃗?  is the distance vector from the center position of the donor to that of acceptor. The 
above relation shows that FRET is the non-radiative energy transfer, in which energy 
from the excited state of the donor (𝐷∗) directly transfers to the ground state of the 
acceptor (𝐴), thereby the donor quenched to the ground state (𝐷) with the coincident 
excitation of the acceptor (𝐴∗), followed by the fluorescence emission of the acceptor 
(Fig. 2.1.).  
 
An explicit formula for the rate of the energy transfer was firstly derived by 









     ∙∙∙ (∗) 
Figure 2.1. Physical principle of FRET with Jablonski diagram. FRET occurs via dipole-
dipole interaction of donor (𝝁𝑫⃗⃗⃗⃗  ⃗) and acceptor (𝝁𝑨⃗⃗ ⃗⃗  ) molecules when the donor emission and 
acceptor absorption energies are resonant. 
９ 
where 𝑅 is the inter-fluorophore distance, 𝜏𝐷° is the lifetime of the excited state 





−1 where 𝑘𝐷𝑓𝑙 and 
𝑘𝐷𝑛𝑟  are the fluorescence and any other non-radiative decay rates of the donor, 
respectively), and 𝑅0  is the characteristic distance, called Förster radius, which 
depends on the photophysical properties of the two fluorophores of the FRET pair. 
This equation indicates not only that the FRET rate depends on the inverse sixth 
power of inter-fluorophore distance but also that the FRET occurs in the time order 
of 𝜏𝐷°, which is typically in ns order for excited singlet state. In detail, the Förster 
radius depends on four other terms according to the following relation: 
𝑅0 = (8.79 × 10
−5 ∙ 𝑛−4 ∙ 𝜙𝐷 ∙ 𝜅
2 ∙ 𝐽)1/6 [Å] 
where 𝑛 is the refractive index of the medium, 𝜙𝐷 is the fluorescence quantum 
yield of the donor, 𝜅2  is the factor for relative orientation between the dipole 
moments of the donor and acceptor, and 𝐽 in the unit of [nm4M-1cm-1] is the spectral 
overlap between donor emission and acceptor absorption spectra. For the orientation 
factor, 𝜅2, it can be calculated by the following equation (Fig. 2.2, left): 
𝜅2 = (cos𝜃𝐷𝐴 − 3cos 𝜃𝐷𝑅 cos 𝜃𝐴𝑅)
2  
where 𝜃𝐷𝐴 is the angle between the donor dipole moment,  𝜇𝐷⃗⃗ ⃗⃗  , and acceptor dipole 
moment,   𝜇𝐴⃗⃗ ⃗⃗ , 𝜃𝐷𝑅  is the angle between 𝜇𝐷⃗⃗ ⃗⃗   and the inter-fluorophore distance 
vector, ?⃗? , and 𝜃𝐴𝑅 is the angle between 𝜇𝐴⃗⃗ ⃗⃗  and ?⃗? . In most applicative cases, both 
fluorophores are assumed to be freely rotating, which results in the average value of 
2/3 for 𝜅2. Also, for the spectral overlap,  𝐽, it is formulated by the below equation 
(Fig. 2.2, right):  
１０ 
𝐽 = ∫𝑓𝐷(λ) 𝜀𝐴(λ) λ
4 𝑑λ  
where 𝑓𝐷(λ)  is the normalized donor emission spectrum, and 𝜀𝐴(λ)  is the 
normalized absorption spectrum or wavelength-dependent extinction coefficient of 
the acceptor.  
 
      The FRET efficiency, 𝐸𝐹𝑅𝐸𝑇, is defined as the ratio of the transferred energy 
to total energy applied for the donor excitation, which can be expressed as: 
𝐸𝐹𝑅𝐸𝑇 =
transferred energy to acceptor









where 𝑘𝐹𝑅𝐸𝑇 , 𝑘
𝐷
𝑓𝑙 , and 𝑘
𝐷
𝑛𝑟  are as described before. Incorporating the 






where 𝑅  is the inter-fluorophore distance, and 𝑅0  is the Förster radius. This 
equation shows that the FRET efficiency, as well as the FRET rate, depends on the 
Figure 2.2. Schematics of orientation factor and spectral overlap between donor 
emission and acceptor absorption. The left schematics represents the relative orientations 
between the dipole moments of the FRET pairs and distance vector, used for orientation 
factor calculation. The right spectra show the definition of spectral overlap: the overlap 
integral of the donor emission and acceptor absorption spectra. 
１１ 
inverse sixth power of the inter-fluorophore distance and that the physical meaning 
of 𝑅0 is the inter-fluorophore distance for 𝐸𝐹𝑅𝐸𝑇 as 0.5 (Fig. 2.3).  
 
Experimentally, the FRET efficiency can be measured with the fluorescence 
lifetimes or intensities of the donor in the absence and presence of the acceptor 
according to the following equation, derived based on the concept that FRET serves 
as an additional non-radiative relaxation pathway for the excited state of the donor: 
















where 𝜏𝐷−𝐴 and 𝜏𝐷° are the fluorescence lifetime of the donor in the presence and 











−1), and 𝐼𝐷−𝐴 and 𝐼𝐷° are the fluorescence intensities of 
the donor in the presence and absence of the acceptor, respectively (i.e. 𝐼𝐷−𝐴 = 𝐼𝑒𝑥 ∙
Figure 2.3. Inter-fluorophore-distance dependency of FRET efficiency. FRET efficiency 
depends on the inter-fluorophore distance to the inverse sixth power, and the Förster radius 
refers to the distance for 𝑬𝑭𝑹𝑬𝑻 = 𝟎. 𝟓. 
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𝑘𝐷𝑓𝑙 ∙ 𝜏𝐷−𝐴  and 𝐼𝐷° = 𝐼𝑒𝑥 ∙ 𝑘
𝐷
𝑓𝑙 ∙ 𝜏𝐷°  where 𝐼𝑒𝑥  is the total incident light 
intensity for the donor excitation). The above equation can also be expressed in terms 
of the donor (𝐼𝐷) and acceptor (𝐼𝐴) fluorescence intensities when FRET occurs with 
the assumption that 𝐼𝐷° can be expressed as the sum of 𝐼𝐷 and 𝐼𝐴: 







Since most fluorescence microscope or spectrometer mainly detect the fluorescence 
intensity as the signals, this expression is the most widely used formula for the FRET 
efficiency calculation. In further experimental detail, some corrections should be 
applied due to the deviation of the detected raw donor intensity and the raw acceptor 
intensity from the assumption. In general, two correction factors, leakage factor (𝛽) 
and gamma factor (𝛾), are introduced to calculate the true FRET efficiency: 
𝐸𝐹𝑅𝐸𝑇 =
(𝐼𝐴 − 𝛽𝐼𝐷)
𝛾𝐼𝐷 + (𝐼𝐴 − 𝛽𝐼𝐷)
     ∙∙∙ (∗∗) 
where 𝛽 is for the spectral leakage of donor fluorescence into the acceptor detection 
channel, and 𝛾 is for the calibration of the difference between donor and acceptor in 
fluorescence quantum yield (𝜙) and detection efficiency (𝜂): 
𝛾 = (𝜂𝐴/𝜂𝐷) ×  (𝜙𝐴/ 𝜙𝐷). 
This relation, equation (∗∗), is the one that we employed in data analysis for our 
study described in the following chapters. The values of the correction factors 
depend on FRET pairs as well as optical components and detectors; thus, they should 
be determined empirically. For Cy3-Cy5 FRET pair in our experimental setup, 𝛽 
was determined to be 0.15, and 𝛾 to be 1. 
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2.1.3. Total internal reflection fluorescence (TIRF) microscopy 
Single-molecule fluorescence detection, including smFRET, requires high spatial 
resolution in order to discriminate a signal from a single molecule from background 
signals from the nearby other molecules. This can be effectively achieved by the 
sufficient reduction of the excitation volume. Total internal reflection fluorescence 
(TIRF) microscopy enables such reduction by taking advantage of an evanescent 
field generated at the interface where total internal reflection occurs. Thus, the TIRF 
microscopy has widely been applied to observe surface-tethered bio-
macromolecules with fluorescent dyes labeled in real-time at the single-molecule 
level, thereby dissecting microscopic molecular dynamics and kinetics in the 
relevant biological processes. 
 
2.1.3.1. Evanescent wave generation at the interface of total internal reflection 
Total internal reflection (TIR) is an intrinsic physical property of light, occurring at 
the interface between the two media. According to the Snell’s law, an incident light 
from the first medium of the refractive index of 𝑛1 is related to the refracted light 
to the second medium of the refractive index of 𝑛2: 
𝑛1 sin𝜃1 = 𝑛2 sin 𝜃2 
where 𝜃1 and 𝜃2 represent the incident and refracted angle, respectively (Fig. 2.4). 
In case of 𝑛1 greater than 𝑛2, the critical angle (𝜃𝑐) for the incident light, which 
makes the refracted angle be 90, can be calculated: 





This relation shows that when 𝜃1 is equal to 𝜃𝑐, the refracted light propagates along 
the interface between the two media without penetrating to the second medium.  
 
More importantly, when 𝜃1 is greater than 𝜃𝑐, the refracted light becomes 
an evanescent wave propagating along the x-axis (the interface) with exponentially 
decaying amplitude along the z-axis (penetrating direction from the medium 1 to 
medium 2). The physical principle of the generation of the evanescent wave can be 
described as follows. First, the wavevector (𝑘2⃗⃗⃗⃗ ) of the refracted wave in xz-plane is: 
𝑘2⃗⃗⃗⃗ = 𝑘2 sin(𝜃2) 𝑥 + 𝑘2 cos(𝜃2) ?̂? 
For 𝑛1 > 𝑛2  and 𝜃1 > 𝜃𝑐 , sin(𝜃2)  should be larger than 1 regarding the 
following relation: 
Figure 2.4. Schematics of the Snell’s law and TIR. An incident light is refracted at the 
interface between two different media according to the Snell’ law. When the refractive index 
of the incident medium (𝒏𝟏) is larger than the refracted medium (𝒏𝟐), total internal reflection 












Then, cos(𝜃2)  becomes a complex number since cos(𝜃2) = √1 − sin
2(𝜃2) =
𝑖√sin2(𝜃2) − 1. Incorporating this relation to the vector expression for the electric 
field of the refracted wave (𝐸2⃗⃗⃗⃗ ) results in: 
𝐸2⃗⃗⃗⃗ = 𝐸0⃗⃗⃗⃗ 𝑒
𝑖(𝑘2⃗⃗ ⃗⃗  ∙𝑟 −𝜔2𝑡) = 𝐸0⃗⃗⃗⃗  exp [𝑖 {𝑘2𝑥 sin(𝜃2) + 𝑘2𝑧𝑖√sin
2(𝜃2) − 1 − 𝜔2𝑡}] 
where 𝐸0⃗⃗⃗⃗  is the amplitude vector of the refracted electric field, and 𝜔2  is the 
angular frequency (i.e. 𝜔2 = 𝑘2𝑐/𝑛2) with 𝑟  and 𝑡 for the position vector and 
time, respectively. This equation can be arranged into the following formula: 








2  and 𝑘′ =
𝜔2
𝑐
(𝑛1 sin 𝜃1). This relation is the 
physical description of the evanescent wave, characterized by the exponential 
attenuation in the z-axis. Therefore, the intensity of the evanescent wave, which is 
proportional to the square of the electric field (i.e. 𝐼2 ∝ |𝐸2⃗⃗⃗⃗ |
2
), also decays along the 
penetration axis: 




where 𝑑 is the characteristic penetration depth depending on wavelength (𝜆), the 
refractive indices of the two media (𝑛1  and 𝑛2 ), and the incident angle (𝜃1 ) 














In our TIRF microscope, the excitation beam was aligned to be totally 
internal-reflected at quartz-water interface, in which case the penetration depth of 
the generated evanescent wave is calculated to be an approximately 100 nm scale. 
This sufficiently reduced illumination volume enabled specific excitation of the 
surface-immobilized molecules. Together with sparse distribution of single 
molecules at the surface in order to resolve each signals from the single molecules 
in xy-plane (i.e. the surface), the single-molecule observation using TIRF 
microscope was successfully achieved.  
 
2.1.3.2. Experimental setup for the TIRF microscopy 
In our studies, we employed home-built prism-type TIRF microscopy, in which a 
(Pellin-Broca) prism, set on the quartz slide surface, mediates TIR of the incident 
excitation laser beam at the quartz-water interface (Figure 2.5). The critical angle of 
the quartz-water interface for TIF is calculated to be 66: 






) ≈ 66° 
Thus, when the incident angle was aligned to be larger than 66, the laser beam 
totally reflected with generating the evanescent field. To minimize unwanted 
refraction at the prism-quartz interface, the refractive indices of the prism and 




      The fluorescence signals from the surface-immobilized molecules 
illuminated by the evanescent field were collected by a water-type objective lens 
(Olympus UplanSApo 60x, N.A. 1.20) and detected by EMCCD camera with green 
(FRET donor) and red (FRET acceptor) fluorescence split (Figure 2.5). To be 
specific, fluorescence signals, passing through the objective lens, were first filtered 
by an emission filter (ZET405/488/532/642m, Chroma) to remove Rayleigh 
scattering of excitation laser beams, and then focused by a tube lens in the 
microscope body (f = 180 mm) with magnification of 60. The signals were re-
Figure 2.5. Schematics of prism-type TIRF Microscope setup. With setting a prism, 
excitation laser beam is aligned to be totally reflected at the quartz-water interface. 
Fluorescence signals from the molecules at the interface are collected by the objective lens, 
spectrally split by dichroic mirror, and then detected by EMCCD camera separately. 
１８ 
collimated by an achromatic lens (f = 100 nm), followed by the spectral splitting via 
dichroic mirror (645dcxr, Chroma). The separated fluorescence signals were re-
focused by another lens (f = 150 nm) on the EMCCD camera (iXon DU-897 ECS-
BV, Andor) with another magnification of 1.5. 
2.1.4. Enhancement of single-fluorophore photo-stability 
2.1.4.1. Oxygen scavenger 
Since oxygen molecules are highly reactive due to the unpaired electrons even at 
their electronically ground state, small organic fluorophores, commonly employed 
in single-molecule fluorescence studies, readily undergo photo-oxidization reaction 
with oxygen molecules, which permanently photo-bleaches the fluorophores. 
Therefore, for the long-time observation of single molecules, the oxygen species 
should be effectively removed in order to protect the fluorophores from the photo-
bleaching. In our single-molecule study, two kinds of enzyme-utilized oxygen 
scavenging systems were employed: glucose oxidase and catalase (GOC)22 and 
pyranose oxidase and catalase (POC)23. The reaction mechanism of these enzymatic 
systems are as follows: 
β-D-glucose + 𝑂2 +𝐻2𝑂 
glucose oxidase
→            gluconic acid + 𝐻2𝑂2 
β-D-glucose + 𝑂2 +𝐻2𝑂 
pyranose oxidase
→              2-dehydro-D-glucose + 𝐻2𝑂2 
𝐻2𝑂2
catalase




These two systems both removes dissolved oxygen molecules effectively, but the 
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difference is that the GOC system drops the pH of the solution whereas the POC 
system does not, by which POC becomes more suitable for the long-term observation, 
particularly, of pH-sensitive systems, e.g. biological systems.  
 
2.1.4.2. Triplet quencher 
Although inducing photo-bleaching of the organic fluorophores, the molecular 
oxygen effectively quenches the triplet states of the fluorophore to the electronically 
ground state, thereby reducing photo-blinking, which occurs when the excited 
fluorophore becomes trapped at the long-lived, non-fluorescent triplet states for, 
typically, μs ~ ms time scale. Thus, with the removal of the molecular oxygen via 
the oxygen scavengers, a triplet quencher (typically a reducing agent mixed with its 
oxidized form) should be incorporated in order to suppress the photo-blinking.  
In our single-molecule fluorescence study, we used Trolox ((±)-6-hydroxy-
2,5,7,8-tetramethylchromane-2-carboxylic acid), the most widespread triplet 
quencher employed in single-molecule fluorescence detection. The Trolox solution, 
prepared by the partial photo-oxidization of Trolox to Trolox-quinone, quench the 
triplet states of fluorophores effectively via rapid redox reactions coupled with 
Trolox (a reductant) and Trolox-quinone (an oxidant)24 (Fig. 2.6). Therefore, the 
triplet quencher along with the oxygen scavenging system dramatically enhances the 




2.2. CRISPR/Cas9 System 
CRISPR (clustered regularly interspaced short palindromic repeats) / Cas9 
(CRISPR-associated protein 9) system is one type of prokaryotic adaptive immune 
system, which distinguishes and degrades foreign DNA. The system employs only 
one protein component, Cas9, to structure a functional ribonucleoprotein effector 
complex with two guide RNAs (gRNAs), CRISPR RNA (crRNA) and trans-
activating crRNA (tracrRNA)7, in which tracrRNA holds Cas9 and crRNA together 
by base-pairing and RNA-protein interaction, respectively (Fig. 2.7). The Cas9-
gRNA effector complex (Cas9:gRNA) binds to the target DNA sequences via 
recognition of short nucleotide sequences called protospacer-adjacent motif (PAM) 
in the target DNA and the complementary base-pairing between crRNA and the 
target DNA8–10. In this section, we summarize the previous reports on the mechanism 
of action of the CRISPR/Cas9 system, focusing on the gRNAs. 
Figure 2.6. Chemical structural formulas for Trolox and Trolox-quinone. Trolox and 
Trolox-quinone undergo numerous cycles of interconverting redox reactions, thereby 
quenching triplet states of excited organic fluorophores. 
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2.2.1. Structural rearrangement of Cas9 induced by guide RNA 
Most structural characteristics of apo-Cas9, Cas9:gRNA, and Cas9:gRNA:DNA 
complex have been revealed by X-ray crystallography and electron microscopy, one 
of which is the global structural rearrangements of Cas9 protein domains upon gRNA 
and DNA binding (Fig. 2.8). Specifically, the single-particle electron microscopy 
showed that the nuclease lobe, composed of nuclease domains and PAM-interacting 
(PI) domain, rotates upon gRNA binding in order to open the DNA-binding channel, 
buried deep inside the apo-Cas9 structure, and re-closes upon DNA binding to hold 
and cleave the DNA19. The X-ray crystallographic study further revealed the details 
on the conformational rearrangement that the PI domain pre-organizes with gRNA 
Figure 2.7. Cartoon for Cas9:gRNA:DNA complex. CRISPR/Cas9 system functions in the 
form of Cas9:gRNA complex, which consists of Cas9 endonuclease with two guide RNAs 
(crRNA and tracrRNA). Cas9:gRNA binds to target DNA via PAM interaction and crRNA-
DNA base-pairing and then cleaves the DNA with nuclease domains. The figure is modified 
from the ref. 10. 
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binding primed for PAM recognition accompanied by the PAM-proximal pre-
organization of gRNA primed for DNA-RNA heteroduplexation18. With crystal 
structures of Cas9:gRNA:DNA20, the HNH nuclease domain was revealed to move 
for cleavage competency from the PAM-distal region toward PAM-proximal 
cleavage site upon gRNA and DNA binding. These structural reports indicate that 
the Cas9 protein needs multi-steps for structural activation, which is closely related 
to gRNA. 
 
2.2.2. Mechanism of gRNA-DNA heteroduplexation in Cas9:gRNA:DNA 
complexation 
One of the most distinctive features of the Cas9 endonuclease is that it lacks a 
helicase domain; it unwinds target double-stranded DNA (target dsDNA) without 
consumption of ATP. The thermal-energy-derived unwinding of the target dsDNA, 
thus, largely relies on the heteroduplexation of complementary strand of the target 
dsDNA with crRNA, which stabilizes the unwound single-stranded DNA. 
Biochemical competition assays suggested that the dsDNA melting and crRNA-
Figure 2.8. Structural rearrangement of Cas9 domains coupled with incorporation of 
gRNA and DNA. Cas9 undergoes multiple structural rearrangements during the 
Cas9:gRNA:DNA complex formation. The figure is modified from the ref. 18. 
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DNA heteroduplexation, i.e. R-loop structure formation, proceed unidirectionally 
after the PAM recognition, from the PAM-proximal bases to the PAM-distal ones15 
(Fig. 2.9). Other studies employing ChIP (Chromatin immunoprecipitation)25 and 
magnetic tweezer26 corroborated the hypothesis of unidirectional R-loop expansion, 
and further revealed the importance of the ‘seed’ nucleotides (approximately 6 ~ 12 
bases from the PAM-proximal end) for the formation of the stable Cas9:gRNA:DNA 
ternary complex; off-target DNAs containing fully matched seed bases with 
mismatched PAM-distal bases recruited Cas9:gRNA effectively. These discoveries 
imply the structural flexibility on the PAM-distal region in the R-loop structure. 
 
2.2.3. Nuclease activity of Cas9 related to PAM-distal complementarity 
between crRNA and DNA 
In contrast to the above reports, in vivo study on nuclease activity of the Cas9 
complex reported that crRNA with 1 ~ 3-nt truncation from the PAM- distal end 
retains catalytic activity of Cas9:gRNA whereas more than 3-nt removal abolishes 
Figure 2.9. Unidirectional heteroduplexation as the mechanism of Cas9:gRNA-dsDNA 
binding. Cas9:gRNA complex binds to target dsDNA with the directionality from the PAM-
proximal end to PAM-distal end. The figure is modified from the ref. 15. 
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the activity nearly to zero27. In particular, the nuclease activity dropped dramatically 
within only 1-nt difference (i.e. ~90% activity for 3-nt truncation versus ~0% activity 
for 4-nt truncation), indicating that the activity collapse is not attributed to gradual 
destabilization of the crRNA-DNA heteroduplex due to the shortening of the base-
pairing length. Furthermore, recent ensemble-FRET spectroscopic study revealed 
that the PAM-distal complementarity of DNA to crRNA directly affects the nuclease 
activity of the Cas9 complex along with structural activation of the HNH nuclease 
domain28 (Fig. 2.10). Therefore, these previous reports suggest that the PAM-distal 
heteroduplexation between crRNA and DNA serves as an allosteric regulator for the 
structural activation of the HNH nuclease domain of Cas9. Given the afore-discussed 
structural flexibility of crRNA on the PAM-distal region, sub-populational analysis 
and molecular dynamics study are required to understand the molecular-level 
association between the PAM-distal flexibility and the allosterically regulated 
nuclease activity of the Cas9 complex. 
Figure 2.10. Structural activation of HNH-nuclease domain by PAM-distal 
complementarity. PAM-distal mismatches between crRNA and DNA abrogates HNH-
nuclease-domain movement and thereby the nuclease activity. The figure is modified from 
the ref. 28. 
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3. Inhibitory Effect of tracrRNA on   








For the formation of CRISPR/Cas effector complex, type-II CRISPR/Cas9 system 
requires tracrRNA as well as crRNA, whereas the other types only need crRNA as 
gRNA. According to X-ray crystallographic studies17,18, tracrRNA interacts 
extensively with Cas9 throughout its full length, proving its importance in 
stabilization of functional Cas9:gRNA. Furthermore, in vivo biochemical approach 
reveals that tracrRNA binds to pre-crRNA, transcribed from CRISPR locus in 
genomic DNA, thereby inducing crRNA-maturation mediated by Cas9 and 
RNaseIII5. Although these previous reports showed that tracrRNA is critical for the 
formation of mature Cas9:gRNA, the sequential process of crRNA-tracrRNA-Cas9 
complexation was still unknown; whether (pre-)crRNA hybridizes to tracrRNA first, 
followed by Cas9 binding or (pre-)crRNA binds to already-formed Cas9-tracrRNA 
binary complex. Thus, this chapter deals with our investigation into the sequential 
assembly of Cas9, tracrRNA, and crRNA for the formation of functional Cas9:gRNA, 
monitored by single-molecule DNA-cleavage assay, and the newly unveiled 
structural role of tracrRNA in the formation process of Cas9:gRNA. 
3.2. Materials and Methods 
Materials – DNA, Cas9, and RNA: DNA oligonucleotides for the target DNA 
were purchased from Integrated DNA Technologies. 5’-end biotinylation was 
introduced to non-complementary strand for surface-immobilization, and internal 
amino modification for fluorescent dye labeling was incorporated in both DNA 
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strands. Cy3 and Cy5 fluorophores were conjugated to the modified amino group of 
the non-complementary strand and complementary strand, respectively, by 
nucleophilic substitution reaction between amino-modified thymine and NHS ester-
linked fluorescent dyes according to the well-established protocol29. Double-
stranded target DNA was prepared by annealing the Cy3-linked (biotinylated) non-
complementary strand with (Cy5-linked) complementary strand at the molar ratio of 
1:1.2 (50μM for the non-complementary strand) in buffer condition of 25 mM Tris 
pH 8.0 and 250 mM NaCl. The annealing was conducted by heating the mixture to 
95 C for 2 min, followed by slow cool-down for approximately 3 hr.  
Cas9 protein from S. pyogenes (SpyCas9) was prepared by overexpression 
from E. coli. Recombinant SpyCas9 gene containing a nuclear localization signal, 
HA epitope, and His-tag at the N-terminus was subcloned into pET28-b(+), then 
overexpressed in BL21(DE3) strain, purified using Ni-NTA agarose beads (Qiagen), 
dialyzed against 20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, and 10% glycerol, 
and finally, concentrated using Ultracel 100K cellulose column (Millipore). The 
purity and concentration of Cas9 protein were quantified by SDS-PAGE.  
Guide RNAs (both tracrRNA and crRNA) were prepared by in vitro 
transcription using MEGAshortscript T7 kit (Ambion) according to the 
manufacturer’s manual. Transcribed RNAs were purified by phenol:chloroform 
extraction, chloroform extraction, followed by ethanol precipitation. The 
concentration of the purified RNAs was quantified by UV-Vis spectrometry. All 
RNA-containing solutions were prepared with nuclease-free water with all 
disposable tips and microcentrifuge tubes qualified as RNase-free and all 
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experimental devices and lab space treated with 70% ethanol.  
All the RNA and DNA sequences with the positions of biotin and internal 
amino modifications are listed in Appendix. 
 
Single-molecule DNA-cleavage assay: For each single-molecule observation, a 
flow chamber composed of a microscope slide and a coverslip, sealed with double-
sided tapes and epoxy, was assembled. Two tiny holes were made on the microscope 
slide before the assembly of the flow chamber so that they work as an inlet and outlet 
for solution exchange. All coverslips and quartz slide glasses were passivated by 
poly-ethylene-glycol (PEG) to prevent nonspecific binding of samples to the glass 
surface30. All imaging and DNA-cleavage reaction were performed at 37 C (unless 
otherwise specified) in the buffer composition of 100 mM NaCl, 50 mM Tris-HCl 
pH 7.9, 10 mM MgCl2, 1 mM DTT and 0.1 mg/ml BSA with the oxygen scavenger 
(2.7 U/ml of pyranose oxidase (Sigma-Aldrich), 7.5 U/ml of catalase (Sigma-Aldrich) 
and 0.4% (w/v) of D-glucose) and the triplet quencher (~2 mM Trolox) in order to 
enhance photostability of the organic fluorophores23.  
For the single-molecule cleavage assay, the DNA-cleavage efficiencies were 
measured after 5-min incubation of 2 nM Cas9 and 300 nM gRNAs with the surface-
immobilized DNA unless otherwise stated.  
 
Set-up and data analysis: We conducted all single-molecule cleavage assays with 
home-built total internal reflection fluorescence microscopy described in Chapter 2. 
A 532 nm green laser (Samba, Cobolt AB) and 633 nm He-Ne laser (25-LHP-925-
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230, Melles-Griot) were employed simultaneously to excite Cy3 and Cy5 molecules, 
respectively. The detected fluorescence images were recorded by a homemade C++ 
script (available for download at https://cplc.illinois.edu/software). 
The ratio of cleaved DNA was calculated by comparing the quantified 
number of Cy3 and Cy5 molecules on the DNA before the injection of the 
reconstituted Cas9:gRNA, and after 7 M urea-treatment to the flow chamber. IDL 
and MATLAB codes were built to count the number of Gaussian-fitted spots from 
the recorded images and then to calculate the average of (the number of Cy3 
molecules)/(the number of Cy5 molecules) in order to take photo-bleaching and/or 
urea-mediated denaturation of the DNA duplex into account. To obtain DNA-
cleavage efficiency at pseudo-ensemble level, data from more than 10 measurements 
were collected with each measurement recording signals from over 300 molecules 
simultaneously. 
 
Circular dichroism (CD) measurement: CD spectra of apo-Cas9 protein were 
obtained using Chirascan plus (Applied Photophysics) over the range of 190 to 260 
nm at indicated temperatures. The data acquisition was performed with 1 nm-interval 
between 190 and 260 nm with triplicate wave-scans, and Peltier-type temperature 
controller controlled the sample temperature from 25 to 37 ºC. Concentration of the 
apo-Cas9 sample for the measurement was 1 mg/ml in buffer composition of 20 mM 




Thermal melting curve measurement: Thermal melting curve of apo-Cas9 and 
Cas9-crRNA mixture were obtained by monitoring the change in the ratio of intrinsic 
tryptophan fluorescence intensity at the emission wavelengths of 330 nm and 350 
nm with fixed excitation wavelength at 280 nm using fluorescence spectrometer 
(Quantamaster, Photon Technology International), while raising temperature. 
Concentration of the apo-Cas9 for the tryptophan fluorescence measurement was 1 
μM, and the concentration of crRNA was 1.5 μM in buffer composition of 10 mM 
Tris-HCl pH 7.4, 300 mM NaCl, 1 mM DTT, 10% glycerol.  
3.3. Results and Discussion 
3.3.1. Visualization of Cas9 nuclease activity at single-molecule level 
To observe nuclease activity of Cas9:gRNA at single-molecule level, total internal 
reflection fluorescence microscopy was employed. We designed biotinylated 48-bp 
double-stranded DNA (dsDNA) dual-labeled with Cy3 and Cy5 fluorophores at the 
vicinity of 5’-end of each strand respectively and tethered to passivated surface via 
biotin-neutravidin interaction, enabling single-molecule detection of dual-labeled 
dsDNA (Fig. 3.1a for the scheme and Appendix for the sequence).  
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Cas9 (2 nM) was pre-incubated with excess gRNAs (300 nM) for 20 min at 
37 C to form Cas9:gRNA, followed by the injection of the Cas9-gRNA mixture 
onto the surface-immobilized target DNA. The DNA-cleavage reaction by 
Cas9:gRNA, through dissociation of cleaved DNA fragments, was monitored after 
the injection of Cas9:gRNA by calculating the ratio of the number of Cy5 molecules 
to that of Cy3 molecules. Consistent with a previous study reporting that Cas9:gRNA 
remains bound to the DNA even after the DNA cleavage15, no change in the number 
of Cy3 and Cy5 molecules was detected upon the incubation of Cas9:gRNA to the 
DNA at 37 C (Fig. 3.1b). To explicitly observe the dissociation of the cleaved DNA 
fragment and Cas9:gRNA from the immobilized fraction of the DNA, 7 M-urea 
solution was injected, as previously applied15, followed by rapid wash-out in order 
to prevent urea-mediated denaturation of biotin-neutravidin interaction or DNA 
Figure 3.1. Single-molecule fluorescence visualization of DNA cleavage by Cas9:gRNA. 
(a) Schematics of surface-immobilized dual-labeled DNA (the distance between Cy3 and Cy5 
is far enough for negligible FRET), targeted and cleaved by Cas9:gRNA. (b) CCD images 
showing single-molecules of the DNA before and after the cleavage reaction of Cas9:gRNA. 
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double-helix structures which could mislead the calculated cleaved-DNA ratio. After 
the urea-treatment, the ratio of the number of Cy5 to Cy3 molecules decreased 
significantly, indicating that the immobilized target DNA was efficiently cleaved by 
Cas9:gRNA; approximately 80% of target DNAs were cleaved in 5 min (Fig. 3.1b 
and Fig. 3.3). However, when Cas9 was replaced by dCas9 (a catalytically ‘dead’ 
Cas9 by introducing point-mutations at the catalytically active sites, D10A and 
H840A) as a negative control, negligible fraction of DNAs were cleaved (Fig. 3.2), 
verifying that the observed 80% loss in Cy5 molecules are predominantly attributed 
to the DNA-cleavage activity of Cas9:gRNA. 
 
By varying incubation time of Cas9:gRNA with the target DNA, Cas9-
induced DNA-cleavage kinetics was investigated. The enzymatic kinetic curve was 
well-fitted by a single-exponential fit (Fig. 3.3), suggesting that the reaction 
mechanism of the target-DNA cleavage by Cas9:gRNA contains a first-order rate-
determining step (RDS). The result that the decay constant of the single-exponential 
Figure 3.2. Single-molecule DNA-cleavage assay using dCas9. As a control, the single-
molecule DNA-cleavage assay with dCas9 instead of catalytically active Cas9 results in the 
cleaved DNA ratio at background level (i.e. DNA only case) (mean ± SEM, n ≥ 5). 
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fit varies with the concentration of Cas9 implies that the pseudo-first-order rate 
constant depends on the concentration of Cas9, indicating that the binding of 
Cas9:gRNA to the target DNA is the RDS for Cas9:gRNA functioning.  
 
3.3.2. Identification of inactivated apo-Cas9 in the absence of tracrRNA 
To explore the sequential roles of gRNAs in the DNA-cleavage activity, we 
compared the DNA-cleavage efficiency from different sets of partially pre-incubated 
Cas9-gRNAs mixtures using the single-molecule DNA-cleavage assay described 
above. Three different sequential processes of pre-incubation and mixing scheme 
were employed before the injection of the mixture onto the immobilized DNA (Fig. 
3.4a): (i) apo-Cas9 and tracrRNA pre-incubated at 37 C for 20 min, and crRNA 
Figure 3.3. Kinetic curves of Cas9-mediated DNA-cleavage reaction at various Cas9 
concentrations. Kinetic analysis of the cleavage reaction shows single-exponential kinetics, 
in which the rate constant depends on concentration of Cas9. With 2 nM of Cas9, around 
80% of DNA molecules were cleaved in 5 min (black arrow). 
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added afterwards; (ii) apo-Cas9 and crRNA pre-incubated at 37 C for 20 min, and 
tracrRNA added afterwards; and (iii) apo-Cas9 alone pre-incubated at 37 C for 20 
min, and both tracrRNA and crRNA added afterwards. Additionally, apo-Cas9 pre-
incubated at 37 C for 20 min with both gRNAs (‘full complex’) was employed as a 
positive control. The cleavage efficiency was then measured at 37 C after an DNA-
Cas9:gRNA incubation time of 5 min, the time enough to reach maximum cleavage 
under our experimental conditions (Fig. 3.3).  
 
 
Figure 3.4. Inactivation of apo-Cas9 in the absence of tracrRNA. Schematics of the 
experimental processes (a) and DNA-cleavage results (mean ± SEM, n ≥ 5) (b) for partial 
pre-incubation experiments. (c) Thermal melting curve of Cas9-crRNA mixture shows phase 
transition at 45 C, identical to the melting temperature of apo-Cas9 (Fig. 3.5c). 
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In the case of Cas9 partially pre-incubated with tracrRNA ((i) in Fig. 3.4), 
the efficiency of DNA cleavage was identical to that of the ‘full complex’, both of 
which reached approximately 80% (Fig. 3.4b, magenta and green bars). Also, as a 
control, the cleavage efficiency for the direct injection of the mixture with apo-Cas9, 
crRNA, and tracrRNA to the DNA (‘without pre-incubation’, Fig. 3.4b, gray bar) 
was almost the same with the cleavage efficiency of the ‘full complex’, indicating 
that the 5-min incubation time is actually far enough for both Cas9:gRNA 
complexation and DNA-cleavage reaction to take place. In sharp contrast, however, 
Cas9 pre-incubated in the absence of tracrRNA ((ii) and (iii) in Fig. 3.4) yielded 
much lower cleavage efficiencies around 20% (Fig. 3.4b, yellow and blue bars). 
Considering that Cas9:gRNA:DNA remains stable even after the DNA cleavage, i.e. 
Cas9:gRNA does not undergo multiple turnover cycles in our experimental time 
scale, the different DNA-cleavage efficiencies correspond to the different 
concentrations of functionally active Cas9:gRNA. Thus, these results suggest that 
apo-Cas9 becomes inactivated when pre-incubated in the absence of Cas9-tracrRNA 
interaction, certifying tracrRNA as a prerequisite for the formation of functionally 
active Cas9:gRNA. (In the case of Cas9 pre-incubated with crRNA, one could raise 
the possibility that Cas9 is inactivated by the crRNA-Cas9 interaction, but no stable 
crRNA-Cas9 interaction was observed when comparing the thermal melting curve 





DNA-cleavage efficiency of Cas9 pre-incubated without tracrRNA (process 
(ii) in Fig. 3.4a) also strongly depended on the pre-incubation temperature; the 
cleavage efficiency decreased as the pre-incubation temperature increased (Fig. 3.5a). 
The result suggests that the transition of functionally active apo-Cas9 into 
inactivated apo-Cas9 requires to overcome an energy-barrier pathway. Temperature-
dependent circular dichroism (CD) spectra show that the energy-consuming 
transformation from active apo-Cas9 to inactivated apo-Cas9 is accompanied by 
conformational change (Fig. 3.5b). As the pre-incubation temperature increased 
from 25 to 37 C, the ellipticity of apo-Cas9 in the characteristic band (210 ~ 220 
nm) changed accordingly (from the black to the green curve). By contrast, when apo-
Cas9 is annealed slowly from 37 to 25 C, no reverse change was detected (the 
dashed red curve), indicating that the reverse conformational rearrangement from the 
inactivated state to the active one is not allowed thermodynamically. To examine 
whether the observed conformational transition is derived from unfolding or phase 
transition of apo-Cas9 or not, we obtained thermal melting curve of apo-Cas9 by 
measuring the shift of intrinsic tryptophan fluorescence (Fig. 3.5c). The melting 
temperature of apo-Cas9 was calculated to be 48.5 °C with only 2% of apo-Cas9 
denatured at 37 °C, verifying that the conformational transition from active apo-Cas9 
to inactivated apo-Cas9 is not related to thermal denaturation or phase transition of 
apo-Cas9. Taken together, these results suggest that there exists another 
conformational state of apo-Cas9, inactivated apo-Cas9, which is 
thermodynamically more stable than the active one, but the structural transition 





Figure 3.5. Temperature-dependency of the apo-Cas9 inactivation. (a) Quantification of 
DNA-cleavage ratio with increasing pre-incubation temperature for process (ii) in Fig. 3.4a 
(mean ± SEM, n ≥ 5). (b) CD spectra of apo-Cas9 at various temperatures. (c) Thermal 
melting curve of apo-Cas9. 
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3.3.3. tracrRNA-involved recovery to functionally active Cas9:gRNA 
Next, to determine whether inactivated apo-Cas9 binds to gRNAs to form 
functionally active Cas9:gRNA, we ran the cleavage assay with annealed apo-Cas9 
prepared as in Fig. 3.5b (dotted curve) after another 1-hr pre-incubation of annealed 
apo-Cas9 with two gRNAs at 22 C (Fig. 3.6a). The result was the DNA-cleavage 
efficiency of only around 20%, similar to those from (ii) and (iii) in Fig. 3.4b (Fig. 
3.6b). Considering the aforementioned result that inactivated apo-Cas9 is trapped at 
lower temperatures, this data shows that tracrRNA does not interact with inactivated 
apo-Cas9 to catalyze reverse conformational rearrangement of inactivated apo-Cas9 
toward active apo-Cas9 or toward the formation of functionally active Cas9:gRNA 
at least without sufficient thermal energy.  
Figure 3.6. DNA-cleavage assay with annealed apo-Cas9. (a) Schematics of experimental 
process for the DNA-cleavage assay with annealed apo-Cas9. (b) The DNA-cleavage 
efficiency of annealed apo-Cas9 was comparable to that of pre-incubated apo-Cas9 at 37 C 
despite of 1-hr pre-incubation time with gRNAs at 22 C (mean ± SEM, n ≥ 5). 
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We revisited the cleavage assay with inactivated Cas9, using longer DNA 
incubation time for the thorough investigation of the rearrangement kinetics from 
inactivated apo-Cas9 to functionally active Cas9:gRNA at the elevated temperature 
(37 C). The pre-formed inactivated apo-Cas9 species as in Fig. 3.4a (ii) and (iii) 
were incubated with the immobilized DNA right after the addition of the other gRNA 
components, i.e. tracrRNA for (ii) and both tracrRNA and crRNA for (iii). The result 
shows that inactivated apo-Cas9 recovered its full cleavage activity after about 20 
min of DNA-incubation in both cases (Fig. 3.7), implying that the thermal energy at 
the elevated temperature is sufficient to overcome the energy barrier for the 
conformational rearrangement which blocks the rearrangement at the lower 
temperature (22 C). Kinetically, the cleavage efficiency started to arise after a lag 
phase of approximately 10 min under our experimental condition. The presence of 
the lag phase suggests the existence of slow-rate steps in the reaction mechanism, 
which could be attributed to the large-energy-barrier conformational rearrangement 
of inactivated apo-Cas9 involving tracrRNA. Therefore, these results reveal that the 
Cas9-tracrRNA interaction prevents Cas9 from transitioning into inactivated apo-
Cas9 by shifting the chemical equilibrium away from the inactivated conformation 












Figure 3.7. Kinetic curves for the recovery of DNA-cleavage activity of inactivated apo-
Cas9. The DNA-cleavage efficiencies of inactivated apo-Cas9 species (with the pre-
incubation processes (ii) and (iii) in Fig. 3.4a) were recovered after extended DNA-
incubation time in the presence of tracrRNA with sufficient thermal energy (error bars 
represent s.d.). 
Figure 3.8. Schematic model for the tracrRNA-mediated formation pathway of 
functionally active Cas9:gRNA.  
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3.4. Conclusion 
In this study, the role of tracrRNA in the formation of the functionally active Cas9 
effector complex was investigated using the single-molecule DNA-cleavage assay. 
We demonstrated that tracrRNA is required to retain the suitable conformation of 
apo-Cas9 for functional Cas9-gRNA complexation at the physiological temperature 
(37 C). Unlike previously reported conformational rearrangement upon gRNA 
binding18 and target DNA hybridization16,17,20, we found another type of 
conformational transition in apo-Cas9 itself without gRNA or DNA interactions 
although its in vivo relevance remains to be addressed by further studies. The fact 
that apo-Cas9 becomes inactivated in the absence of tracrRNA suggests that active 
apo-Cas9 first recognizes tracrRNA prior to crRNA binding during the formation 
process of Cas9:gRNA. This in vitro result could shed some light on the role of Cas9 
and tracrRNA in the crRNA-maturation process, described in the introduction, in 
which tracrRNA may be recognized by Cas9 and then the Cas9-tracrRNA complex 
be recruited to pre-crRNA, similar to the Cas9-gRNA complexation process 
established in this study. 
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4. Regulatory Effect of Sub-conformational    
Transition of crRNA on                      








In CRISPR/Cas adaptive immunity, crRNA is a key component owing to its 
exclusive role in target specificity; it specifically binds to target DNA by base-pairing. 
In type-II CRISPR/Cas9 system, several studies have proposed that the base-pairing 
between crRNA and DNA forms unidirectionally. The unidirectional R-loop 
expansion from PAM-proximal end to PAM-distal end was first suggested based on 
biochemical competition assay15 and supported by single-molecule observation of 
R-loop formation using a magnetic tweezer26,31. However, the intrinsic dynamics of 
the R-loop expansion was still enigmatic; the biochemical assay lacked dynamic 
information, and the employment of the magnetic tweezer distorted the intrinsic 
dynamics due to the exerted force. Hence, we looked deep into the innate dynamic 
properties of the R-loop expansion between crRNA and the target DNA. This chapter 
discusses our single-molecule observation of the R-loop structure, subsequent 
discovery of newly identified R-loop sub-conformations, and the regulatory role of 
the sub-conformational transition in nuclease activation of Cas9:gRNA:DNA.  
4.2. Materials and Methods 
Materials - Cas9, RNA, and DNA: Cas9 and dCas9 from S. pyogenes were 
overexpressed from E. coli or purchased from New England Biolabs. In the case of 
home-expressed proteins, the sample preparation procedure was the same with that 
described in Section 3.2. We checked the catalytic activity and DNA-binding affinity 
of the home-expressed Cas9 and confirmed that they were comparable to those of 
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the purchased Cas9 upon our experimental conditions.  
Guide RNAs were prepared by in vitro transcription as described in Section 
3.2 or purchased from ST Pharm, while all Cy5-labeled crRNAs were purchased 
from ST Pharm with HPLC-purification. Just as for experiments in Chapter 3, all 
RNA-including solutions were prepared with nuclease-free water with all disposable 
tips and microcentrifuge tubes certified as RNase-free and all experimental devices 
and lab space pre-treated with 70% ethanol.   
All DNA oligomers with 5’-end biotin and/or internal amino modification 
were purchased from Integrated DNA Technologies, and dye-labeled double-
stranded DNAs were prepared as already described in Section 3.2. 
All the RNA and DNA sequences with the positions of biotin and internal 
amino modifications are listed in Appendix. 
 
Single-molecule assays: The same single-molecule flow chamber and surface-
passivation process were employed in this study with those described in Section 3.2. 
All imaging and binding/cleavage reactions were performed with the following 
buffer composition: 100 mM NaCl, 50 mM Tris-HCl pH 7.9, 10 mM MgCl2, 1 mM 
DTT and 0.1 mg/ml BSA.  
In cleavage/binding measurements and smFRET experiments for FRET 
histograms, the imaging and binding/cleavage reactions were performed at 37 C 
with oxygen scavenger (2.7 U/ml of pyranose oxidase (Sigma-Aldrich), 7.5 U/ml of 
catalase (Sigma-Aldrich) and 0.4% (w/v) of D-glucose) and triplet quencher (~2 mM 
Trolox) as described in Section 3.2. The DNA-cleavage efficiencies were measured 
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after 5-min incubation of immobilized DNA with 2 nM Cas9 and 300 nM gRNAs, 
and the binding affinities and FRET histograms were obtained after 30-min 
incubation of the DNA with 2 nM Cas9 and 30 nM gRNAs with the temporal 
resolution of 500 ms. 
In smFRET experiments for single-molecule time traces, imaging was 
performed at room temperature with different oxygen scavenger (1 mg/ml of glucose 
oxidase (Sigma-Aldrich), 0.04 mg/ml of catalase (Sigma-Aldrich) and 0.8% (w/v) 
of D-glucose) and the addition of 5% (v/v) of glycerol. The time traces were acquired 
intermittently during the incubation (from 0 min to 30 min) of the DNA with 
Cas9:gRNA with the temporal resolution of 30 ms. 
 
Set-up and data analysis: The single-molecule fluorescence assays employed our 
home-built total internal reflection fluorescence microscopy which is described in 
Chapter 2. The only difference is that for smFRET assays, we used a 532 nm green 
laser (Samba, Cobolt AB) alone to excite Cy3 molecules, whereas for cleavage 
assays, a 633 nm He-Ne laser (25-LHP-925-230, Melles-Griot) along with the green 
laser were both turned on to excite Cy3 and Cy5 molecules independently.  
The procedure for the single-molecule cleavage assay was based on the 
quantification of the number of Cy3 and Cy5 molecules, which was identical to that 
described in Section 3.2. The same methodology was also applied to determine the 
bound ratio of Cy5-labeled Cas9:gRNA to Cy3-labeled DNA.  
In the smFRET histograms and time traces, the FRET efficiency was 
calculated according to the following equation: Iacceptor/(Idonor + Iacceptor). The 
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gamma factor, γ, is the correction factor, determined as the ratio of change in the 
acceptor intensity, Iacceptor, to change in the donor intensity, Idonor, when the 
acceptor photo-bleaches in the absence of protein:  = Iacceptor/Idonor = 1 for the 
Cy3-Cy5 pair in our experimental conditions. The other correction factor  was 
introduced reflect the enhancement of acceptor fluorescence intensity upon protein 
binding: the value of  was determined to be 0.5 in our system. To identify FRET 
states and to calculate the transition rates between the states from the single-molecule 
time traces, hidden Markov modelling (HMM) based on variational Bayesian 
expectation maximization was employed32. On the other hand, to determine high-
FRET-state populational ratio from the FRET histogram, an appropriate threshold 
value of FRET efficiency was set to sort high- and low-FRET states.  
4.3. Results and Discussion 
4.3.1. Real-time observation of Cas9:gRNA binding to DNA at single-
molecule level 
For Cas9-induced DNA-cleavage reaction, Cas9:gRNA should bind to the target 
DNA, where unidirectional R-loop expansion between the DNA and crRNA seems 
to be critical for the stabilization and nuclease-activation of Cas9:gRNA:DNA 
(Section 4.1). To search dynamic aspect of the R-loop structure and thereby, to 
elucidate molecular behavior of crRNA during the interaction of Cas9:gRNA with 
DNA, we used single-molecule fluorescence resonance energy transfer (smFRET) 
spectroscopy. A FRET pair between immobilized target DNA and crRNA was 
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introduced to monitor the conformational dynamics during the DNA-crRNA 
hybridization (Fig. 4.1a); Cy3 (the donor) labeled at the 25th nucleotide from the 
PAM site (+25) in non-complementary strand of the DNA and Cy5 (acceptor) at the 
5′-end (20th nucleotide from the PAM site: +20) of crRNA. The real-time smFRET 
observation was successfully demonstrated with the Cy5-Cas9:gRNA incubated with 
‘wild-type’ Cy3-DNA which contains a protospacer with full complementarity to 
crRNA and the right PAM sequence (5’-NGG-3’). After the injection of the mixture 
of Cas9, tracrRNA, and Cy5-crRNA onto the Cy3-DNA, Cy5 molecules, fluoresced 
by FRET from excited Cy3 molecules, appeared gradually, each spot of which 
represented individual real-time binding of Cas9:gRNA to DNA (Fig. 4.1b and c). 
Figure 4.1. Real-time observation of target DNA-Cas9:gRNA binding using single-
molecule FRET. (a) Cartoon for surface-immobilized Cy3-labeled target DNA, bound to 
Cy5-labeled Cas9:gRNA. (b) CCD images showing single-molecules of the DNA and the 
bound Cas9 complex before and after the incubation of Cas9:gRNA with DNA. (c) Kinetic 
curve for Cas9:gRNA binding to the target DNA. 
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4.3.2. Conformational heterogeneity in crRNA-DNA heteroduplex 
Using the smFRET technique, we observed the structural dynamics in the crRNA-
DNA heteroduplex. After Cas9:gRNA and the wild-type DNA equilibrated by 
sufficient incubation (30 min), a FRET histogram exhibited two distinct states of 
Cas9:gRNA:DNA: a high-FRET state (FRET value of 0.83) and a low-FRET state 
(FRET value of 0.27) (Fig. 4.2a, upper histogram). Also, for dCas9 (catalytically 
‘dead’ Cas9, point-mutated at the catalytically active sites, D10A and H840A) in 
place of Cas9, the identical FRET states were observed (Fig. 4.2a, lower histogram), 
indicating that these two different FRET states may represent the sub-conformational 
intermediates during the DNA binding and cleavage process of Cas9:gRNA.  
Figure 4.2. Conformational heterogeneity and dynamics in Cas9:gRNA:DNA. (a) FRET 
histograms for the crRNA-DNA heteroduplex with Cas9 and dCas9. (b) A representative 
single-molecule time-trace for Cas9:gRNA:DNA. (c) Transition density plot for all 
transitions in the time traces. (d) Dwell-time analysis for the high and low-FRET states. 
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To characterize the detailed conformation of each FRET state, we looked into 
single-molecule time traces and designed two other control DNA samples. In the 
single-molecule time traces, the nascent complexes of Cas9:gRNA initially bound to 
the wild-type DNA mostly presented the low-FRET value (Fig. 4.2b). Furthermore, 
when the complementary strand of DNA (complementary to the crRNA) and crRNA 
on the PAM-distal region (+15 ~ +20) are designed to be mismatched (termed ‘mis-
crRNA’ ), only a single low-FRET peak at the value of 0.27 was observed (Fig. 4.3, 
upper panel). These results imply that the low-FRET state corresponds to the PAM-
proximal bound but PAM-distal unbound complex (termed ‘open conformation’), in 
which crRNA hybridizes with the target DNA only partially on the PAM-proximal 
seed region before the completion of the R-loop expansion.  
Figure 4.3. Characterization of the sub-conformations using mismatched DNAs. FRET 
histograms for the two DNAs modified on PAM-distal region (+15 ~ +20). ‘Mis-crRNA’ 
refers to the intact dsDNA, in which the complementary strand is mismatched to crRNA on 
the PAM-distal region, whereas ‘bubble DNA’ refers to the bulged dsDNA, in which the 
complementary and non-complementary strands are mismatched to each other on the PAM-
distal region with the complementary strand fully matched to crRNA. 
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On the other hand, following the formation of the open conformation of 
Cas9:gRNA with the wild-type DNA, transition toward the high-FRET state was 
observed (Fig. 4.2b). Taking available X-ray crystal structures of Cas9:gRNA:DNA 
into account16,17, the high-FRET state was thought to represent the conformation after 
the R-loop completion (termed ‘zipped conformation’) with the observed FRET 
transition from the low-FRET to the high-FRET value relevant to the R-loop 
expansion on the PAM-distal region. Plus, the FRET value of the high-FRET state 
(0.83), calculated to be inter-dye distance of 40 Å , was compatible with the zipped 
R-loop structure considering the closeness between the 5′-end of crRNA and the +25 
position of the non-complementary strand of DNA, revealed by the recent electron 
microscopic study20.  
Surprisingly, the R-loop structure did not remain in the zipped conformation 
even after it transitioned from the open conformation. Rather, a series of transient, 
repetitive transitions between the two conformations was detected (Fig. 4.2b). A 
transition density plot from all the transitions in the single-molecule time traces 
showed only the two peaks (from the low-FRET state to the high-FRET state, and 
vice versa) (Fig. 4.2c), indicating that only the open and zipped conformations are 
the well-defined states in the intrinsically dynamic R-loop structure. In terms of 
kinetics, the dwell-time distributions of the two states were both fitted well by single 
exponential functions (t(Ehigh) = 222 ms  18 ms and t(Elow) = 270 ms  14 ms), 
confirming that each conformation is kinetically a single state (Fig. 4.2d). 
Additionally, removing the complementarity between the two DNA strands on the 
PAM-distal region (+15 ~ +20) (termed ‘bubble DNA’ design), only the high-FRET 
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state was observed in the FRET histogram (Fig. 4.3, bottom panel) without any 
FRET transitions (we note that the high-FRET value of bubble DNA (0.75) is 
evidently lower than that of wild-type DNA (0.83), probably due to the structural 
distortion of the bubble DNA induced by the mismatched bases). This observation 
reinforces our identification that the repetitive FRET transition represents the 
conformational dynamics between crRNA and the complementary strand of DNA at 
the PAM-distal end and that the high-FRET state represents the fully expanded R-
loop conformation, the zipped conformation. Together, these results clearly 
demonstrated the sub-steps of the R-loop expansion in Cas9:gRNA:DNA with the 
direct observation of the conformational sub-populations in the R-loop structure. 
4.3.3. crRNA-controlled conformational distribution in R-loop structure 
in Cas9:gRNA:DNA  
Next, to identify the role of crRNA in the PAM-distal structural dynamics in 
Cas9:gRNA:DNA, truncated crRNA (17-nt crRNA) was employed, in which three 
nucleotides were deleted at the PAM-distal end. We hypothesized that the loss of the 
interaction between truncated crRNA and the complementary strand of DNA on the 
PAM-distal region may lead to a shift in the conformational equilibrium between the 
two R-loop sub-conformations. In agreement with the hypothesis, the FRET 
histogram with a considerably altered distribution was measured after sufficient 
incubation (30 min) with truncated crRNA. In comparison to full-length crRNA (20-
nt crRNA), also the two FRET states were observed whereas their relative 
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populations were reversed (Fig. 4.4a), indicating that the truncation shifts the 
equilibrium toward base-pairing between the two DNA strands on the PAM-distal 
region, i.e. the open conformation (notably, the FRET values of the low and high 
FRET states changed slightly (0.29 and 0.76, respectively), possibly due to the 
change in the inter-dye distance by the truncation of the 3-nt in each state). 
Kinetically, the average dwell time of the high-FRET state (77 ms  9 ms) was 
analyzed to become 3 times shorter than that of 20-nt crRNA (222 ms  18 ms), 
while the dwell time of the low-FRET state remained nearly unchanged (250 ms  
12 ms for 17-nt crRNA and 270 ms  14 ms for 20-nt crRNA) (Fig. 4.4b and c).  
 
These data support that the nucleotide shortening causes a lower binding 
energy of the PAM-distal crRNA-DNA heteroduplex than that with 20-nt crRNA, 
thereby destabilizing the zipped conformation without disturbing the stability of the 
Figure 4.4. Effect of PAM-distal complementarity on the sub-conformational 
distribution and kinetics. (a) FRET histogram for Cas9:gRNA with 17-nt crRNA bound to 
the wild-type DNA. (b) A representative single-molecule time-trace for Cas9:gRNA:DNA 
with 17-nt crRNA. (c) Comparision of each dwell time of the high and low-FRET states 
between 20-nt full-length and 17-nt truncated crRNA (mean ± SEM, n ≥ 3).  
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open conformation. This is also in good agreement with the previous report 
proposing that the underlying principle of improved target specificity of truncated 
crRNA is the 3-nt deletion-derived destabilization of the RNA-DNA interaction to a 
level just endurable for on-target activity but unendurable for off-target activity27. In 
other words, our results demonstrated that the PAM-distal complementarity of 
crRNA to the complementary strand of DNA kinetically affects the conformational 
transition and thereby the distribution between the two R-loop sub-conformations. 
4.3.4. Nuclease activity of Cas9 regulated by the conformational 
transition 
With the aim of correlating the R-loop sub-structural transition with the nuclease 
activity of Cas9, we compared the DNA-cleavage efficiencies of the three DNA 
designs (wild-type DNA, bubble DNA, and mis-crRNA), all of which exhibited the 
different conformational distributions between the open and zipped conformations 
(Fig. 4.2a and 4.3). The wild-type and bubble DNA, in which the zipped 
conformations were available, were cleaved by the Cas9 complex with comparable 
efficiencies, whereas the mis-crRNA, in which binding affinity was at about the same 
level with the other DNAs but remained only in the open conformation, failed to be 
cleaved (Fig. 4.5a). Moreover, kinetic comparison for the Cas9-catalyzed DNA-
cleavage reaction of the wild-type (cleavage rate constant of 0.58/min) and bubble 
DNA (cleavage rate constant of 1.59/min) suggests that the shorter 
Cas9:gRNA:DNA spends time in the zipped conformation, the slower DNA cleavage 
５４ 
occurs (Fig. 4.5b, left plot). This interpretation was further corroborated by the 
kinetics of the DNA-cleavage reaction with 17-nt crRNA (Fig. 4.5b, right plot), in 
which the DNA-cleavage rate (0.07/min) was remarkably reduced due to the 
decrease in the dwell time of the zipped conformation (Fig. 4.4c). These results 
reveal that once the Cas9 complex binds to DNA, dsDNA melting with the crRNA-
DNA heteroduplexation on the PAM-distal region is the rate-determining step for the 
DNA-cleavage reaction; thus, the DNA cleavage is allowed only when the R-loop 
remains stably in the zipped conformation.  
 
      Finally, we varied the R-loop stability using a series of off-target DNAs with 
2-3 mismatched bases from the PAM-proximal to PAM-distal end for the 
comprehensive picture of the relation between the stability of the R-loop structure 
and the DNA-cleavage efficiency of the Cas9 complex from the PAM-proximal to 
PAM-distal region. Cas9:gRNA failed to form the stable Cas9:gRNA:DNA complex 
Figure 4.5. Nuclease activation of Cas9:gRNA by the sub-conformational transition. 
(a) Relative binding affinities and DNA-cleavage activities of Cas9:gRNA for the three 
afore-described DNA constructs (mean ± SEM, n ≥ 5). (b) Kinetic curves of the cleaved 
DNA ratio for the wild-type, bubble DNA and the wild-type DNA with 17-nt crRNA (error 
bars represent s.d.). 
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with the DNAs mutated in the PAM-proximal ‘seed’ region (Fig. 4.6a), as previously 
reported25; the binding affinity of Cas9:gRNA to DNAs arose with at least half of the 
protospacer sequences from the PAM site matched to crRNA. As the mismatched 
position moving toward the PAM-distal end, the DNA-cleavage efficiency increased 
along with the populational increase in the zipped conformation (Fig. 4.6b), 
consistent with the enhancement and reduction of the cleavage efficiency for the 
bubble DNA and 17-nt crRNA construct, respectively. To note, the DNA containing 
mismatches at +10 ~ +11 positions did not transition to the high-FRET state, despite 
9-nt complementarity at the PAM-distal end. This implies that the zipped 
conformation requires not only the crRNA-DNA complementarity on the PAM-distal 
region but the entire heteroduplex stability including the PAM-proximal region, 
which is consistent with the previously proposed unidirectionality of the R-loop 
expansion. Overall, these findings manifest that the observed transition between the 
two conformations is implicated in the enzymatic activation of the Cas9 complex as 
well as the R-loop expansion, rendering the conformational rearrangement a key step 












Figure 4.6. Binding affinity, sub-conformational distribution, and DNA-cleavage 
activity with various mismatched DNAs. (a) Binding affinities of Cas9:gRNA to various 
off-target DNAs, in which the crRNA-complementarity is removed at different positions. (b) 
FRET histograms of the off-target DNAs and the comparison of the high-FRET-state ratio 
with the cleaved-DNA ratio (mean ± SEM, n ≥ 5). 
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4.4. Conclusion 
To summarize, this chapter reported our real-time single-molecule experiments on 
the structural dynamics of crRNA-target DNA heteroduplex, which was found to be 
regulated by the heteroduplex stability and to regulate the Cas9 nuclease activation. 
The R-loop expansion in Cas9:gRNA:DNA was revealed to be a multistep process 
with the dynamic transitions on the PAM-distal region between the two intermediate 
states, open and zipped conformations (Fig. 4.7). This intrinsic structural dynamics 
is consistent with the previously suggested structural flexibility of the Cas9 complex 
deduced from the X-ray crystallography17,18 and with a previous biophysical report 
in which Cas9, in contrast to type-I CRISPR effector complex, was found not to be 
locked after the R-loop completion26.  
 
The transition rate between the two conformations (Fig. 4.2d) was two orders 
of magnitude faster than the DNA-cleavage rate of the wild-type DNA (Fig. 4.5b). 
This discordance of the two rate constants indicates that the formation of the zipped 
conformation alone is insufficient for DNA cleavage although the transition toward 
the zipped conformation is the prerequisite for the cleavage reaction. As several 
structure-based studies have proposed that the HNH nuclease domain of Cas9 moves 
Figure 4.7. Schematic model for the multistep R-loop expansion, followed by DNA-
cleavage reaction. 
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from the PAM-distal region to PAM-proximal cleavage site of the complementary 
strand of DNA17,18,28, it is possible that the transition to the zipped conformation may 
trigger the nuclease domain movement; synchronous real-time single-molecule 
observation for the crRNA-DNA heteroduplex with the HNH domain is required to 
elucidate the correspondence between the two structural rearrangements.   
Off-target DNA sequences with mismatched bases on the PAM-distal region 
formed stable Cas9:gRNA:DNA complex but remained only in the PAM-proximally 
bound, open conformation without transition to the zipped conformation and the 
following DNA cleavage (Fig. 4.5 and 4.6). These experiments with the variable off-
target DNA sequences revealed that the stability of the crRNA-DNA heteroduplex 
controlled the sub-conformational kinetics and distribution in Cas9:gRNA:DNA, 
thereby regulating the nuclease activation of Cas9. In light of this newly unveiled 
role of the kinetics and dynamics in Cas9:gRNA:DNA, it would become possible to 
predict off-target activities more quantitatively, which enables more specific target 









In this thesis, we have discussed our single-molecule and (single-molecule-based) 
pseudo-ensemble studies on the molecular mechanism of CRISPR/Cas9 functioning, 
focusing on the structural roles of gRNAs. To summarize, the background principles 
and characteristics of the single-molecule fluorescence spectroscopic technique and 
CRISPR/Cas system employed in our studies were firstly described. Then, the 
distinct structural roles of tracrRNA and crRNA identified in our studies were 
illustrated sequentially with the details of material preparation and experimental 
procedures.  
With the single-molecule-based pseudo-ensemble DNA cleavage assay for 
different sets of partial pre-incubation processes, conformational change from a 
normally active apo-Cas9 state to an inactivated apo-Cas9 state in the absence of 
tracrRNA was newly uncovered. The transition toward inactivated apo-Cas9 was 
blocked by tracrRNA-Cas9 interaction, leading to the formation of functional 
Cas9:gRNA. On the other hand, real-time monitoring of Cas9:gRNA:DNA using the 
single-molecule FRET assay characterized sub-conformations (open and zipped 
conformation) of the R-loop structure between crRNA and target DNA in 
Cas9:gRNA:DNA, which could not be observable from any other ensemble-
averaged techniques. The importance of this transition between the sub-
conformations was emphasized by its regulatory effect on the nuclease activity of 
Cas9:gRNA:DNA.  
Owing to the powerfulness of the single-molecule spectroscopic technique, 
we distinguished the hidden intermediate states (i.e. inactivated apo-Cas9 and open 
and zipped sub-R-loop conformations) and analyzed their roles in the reaction 
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pathway of CRISRP/Cas9 functioning. Undoubtedly, there still remain uncertain 
points to be addressed: structural characterization of inactivated apo-Cas9, a kinetic 
model for the tracrRNA-involved recovery of the nuclease activity from the 
inactivated state, discrimination of the sub-conformational distributions before and 
after the DNA cleavage, and synchronousness between the open-to-zipped 
conformational transition and the HNH-nuclease-domain movement. Nonetheless, 
we expect that our study would serve as a doorstep to the complete understanding of 
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All DNA and RNA sequences, used in Chapter 3 and 4, are listed below with the 
introduced modifications:  
Description Type Sequences 
wild-type DNA  
in cleavage 
assay 
(Ch. 3 and 4) 
Non-complementary 
strand 
5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAG AAG AAG 
GGC TCC CAT CAC ATC – 3’ 
Complementary strand 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CTG 
CTC GGA CTC AGG CAC TTC 
CTC – 3’ 






5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAG AAG AAG 
GGC TCC CAT CAC ATC – 3’ 
Complementary strand 
5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CTG CTC GGA 





5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT CTC AGG 
GAG CAG AAG AAG AAG 






5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CTG CTC CCT 
GAG AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CTG 
CTC CCT GAG AGG CAC TTC 
CTC – 3’ 




5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT CTC AGG 
GAG CAG AAG AAG AAG 






5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CTG CTC GGA 
CTC AGG CACTTC CTC – 3’ 
For cleavage 5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CTG 
６６ 
assay CTC GGA CTC AGG CAC TTC 






5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAG AAG AAC 






5’ – GAT GTG ATG GGA GGG 
GTT CTT CTT CTG CTC GGA 
CTC AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GGG GTT CTT CTT CTG 
CTC GGA CTC AGG CAC TTC 






5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAG AAG TTG 






5’ – GAT GTG ATG GGA GCC 
CAA CTT CTT CTG CTC GGA 
CTC AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CAA CTT CTT CTG 
CTC GGA CTC AGG CAC TTC 






5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAG ATC TAG 






5’ – GAT GTG ATG GGA GCC 
CTA GAT CTT CTG CTC GGA 
CTC AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTA GAT CTT CTG 
CTC GGA CTC AGG CAC TTC 






5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG CAG AAC TAG AAG 





5’ – GAT GTG ATG GGA GCC 
CTT CTA GTT CTG CTC GGA 





5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTA GTT CTG 
CTC GGA CTC AGG CAC TTC 







5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TCC 
GAG GTG AAG AAG AAG 






5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CAC CTC GGA 
CTC AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CAC 
CTC GGA CTC AGG CAC TTC 







5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT GAG TTA 
GAG CAG AAG AAG AAG 






5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CTG CTC TAA 
CTC AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CTG 
CTC TAA CTC AGG CAC TTC 







5’ – /5Biosg/ttt ttt GAG GAA 
G/iAmMC6T/G CCT CTG TCC 
GAG CAG AAG AAG AAG 






5’ – GAT GTG ATG GGA GCC 
CTT CTT CTT CTG CTC GGA 
CAG AGG CAC TTC CTC – 3’ 
For cleavage 
assay 
5’ – GAT GTG A/iAmMC6T/G 
GGA GCC CTT CTT CTT CTG 
CTC GGA CAG AGG CAC TTC 
CTC – 3’ 
crRNA 
(Ch. 3 and 4) 
ssRNA  
for cleavage assay 
5’ – GGG AGU CCG AGC AGA 
AGA AGA AGU UUU AGA 
GCU AUG CUG UUU UG – 3’ 
tracrRNA 
(Ch. 3 and 4) 
ssRNA 
for both cleavage and 
5’–GGA ACC AUU CAA AAC 
AGC AUA GCA AGU UAA AAU 
AAG GCU AGU CCG UUA 
６８ 
smFRET assay UCA ACU UGA AAA AGU GGC 
ACC GAG UCG GUG CUU 




for smFRET assay 
5’ – /5Cy5/ GAG UCC GAG 
CAG AAG AAG AAG UUU 
UAG AGC UAU GCU GUU 





for smFRET assay 
5’ – /5Cy5/ UCC GAG CAG 
AAG AAG AAG UUU UAG 




for cleavage assay 
5’ – UCC GAG CAG AAG AAG 
AAG UUU UAG AGC UAU 
GCU GUU UUG – 3’ 
 
“Biosg” refers to biotin for surface immobilization, and “iAmMC6T” refers to 
amino-modified carbon-spacer-linked dT for NHS-ester linked Cy3 or Cy5 dye 





원핵생물의 후천면역체계로서 최근들어 새롭게 발견된 크리스퍼 시스
템 (Clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR-
associated (Cas) system) 은 외부의 바이러스나 플라스미드로부터 개체 스
스로를 보호하는 기능을 수행한다. 여러 타입의 크리스퍼 시스템 중, 타
입-II 시스템은 Cas9이라는 핵산절단효소 단백질과 두 가지의 가이드 
RNA (gRNA: CRISPR RNA (crRNA) 와 trans-activating crRNA (tracrRNA))로 
구성되며, 이 구성요소들이 단백질-RNA 복합체를 이루어 표적 DNA 를 
인식하고 절단한다. 이 타입-II 크리스퍼/Cas9 시스템이 차세대 유전자 
조작 기술로 유전공학 분야에 성공적으로 도입되면서, Cas9-gRNA 복합체
에 대한 구조적 특성 연구도 활발히 진행되었다. 그러나 여전히 gRNA가 
Cas9 핵산절단효소를 어떻게 활성화시키는지 그 구조변화에 대한 구체적
인 동역학적 메커니즘에 대한 규명은 이루어지지 않은 실정이다. 
이에, 우리는 단분자 형광 분광법을 도입하여 두 가이드 RNA가 Cas9 
핵산절단효소 활성화에 있어 수행하는 구조적 역할에 대해 연구하였다. 
그 결과, 정적인 앙상블 평균값만을 관찰하는 기존의 실험법들로는 알아
낼 수 없었던 Cas9 시스템 작동 상의 세부적 메커니즘을 규명할 수 있었
으며, 본 학위논문에서는 이 연구에 대해 논하기로 한다. 첫째로, 
tracrRNA는 정상 기능하는 Cas9-gRNA 복합체 (Cas9:gRNA)의 형성과정에 
７０ 
있어 핵심적인 역할을 수행함을 밝혀내었다. tracrRNA가 없는 경우, Cas9 
단백질이 비활성화되어 Cas9:gRNA 형성이 이루어지지 않았다. 반면, 
tracrRNA-Cas9 상호작용이 가능한 경우에는 Cas9:gRNA가 형성되는 반응
경로가 우세해지면서 Cas9의 비활성화는 관찰되지 않았다. 둘째로, 
tracrRNA가 Cas9:gRNA 형성에 관여하는 것과는 달리, crRNA는 
Cas9:gRNA가 표적 DNA와 결합한 Cas9-gRNA-DNA 삼중 복합체 
(Cas9:gRNA:DNA)에서 Cas9 핵산절단효소의 활성화 여부를 조절하는 것
으로 밝혀졌다. Cas9:gRNA:DNA 내의 crRNA와 DNA 사이에 형성되는 R-
loop 구조는 ‘열린 구조 (open conformation)’와 ‘잠긴 구조 (zipped 
conformation)’라고 명명한 두 하위 구조로 존재하며, R-loop 구조는 실제
적으로 이 두 구조를 계속해서 왔다갔다 반복하는 내재적인 동역학적 특
성을 지니고 있음이 발견되었다. 나아가, 잠긴 구조가 만들어져야만 
DNA가 절단된다는 것을 관찰함으로써, 이러한 crRNA와 연관된 구조 동
역학적 특성이 Cas9 절단효소 활성화에 핵심임을 밝혀내었다. 종합하자
면, 이러한 결과들은 Cas9 핵산절단효소의 구조적 활성화에 있어 gRNA
의 역할에 대한 세부 메커니즘 수준에서의 이해를 가능케 하였다. 
 
주요어: 단분자 분광학, 전반사 형광 현미경법, 형광 공명 에너지 
전달, 크리스퍼, 구조 동역학, 효소 메커니즘 
 
학  번: 2015-20386 
